Navigation Links
Global Hemoglobin A1c Monitoring Market to Touch $272 Million by 2012, According to New Report by Global Industry Analysts, Inc.
Date:10/28/2008

World hemoglobin A1c monitoring market is forecast to surpass $272 million by 2012. The market is primarily driven by an ever increasing diabetic population. Other growth drivers include greater glucose control and product innovations that help improve compliance or convenience.

San Jose, CA (PRWEB) October 28, 2008 -- World Health Organization forecasts global diabetic population to increase by 2025 to reach a record 380 million. Globally, an estimated 246 million people are affected by diabetes mellitus, of which less than half have been identified. Of those identified, approximately 10%-20% are insulin dependent. The seriousness of affliction and the need for effective therapy to manage diabetes has led to the emergence of a significant market for monitoring the treatment efficiency of the disease. Other factors such as greater glucose control, product innovations that help improve compliance or convenience comprise other growth drivers in this market.

Diabetes patients (type I) who regularly monitor their HbA1c (hemoglobin A1C) levels attain tight glucose control, thus considerably reducing their vulnerability to a cardiovascular disease. High blood sugar level for a longer period of time could result to increase in risk of heart disease or stroke. An HBA1C level more that 4.6 indicate the person is at increased risk for heart attack. The ADA (American Diabetes Association), recommends an HbA1c test every 3 to 6 months for monitoring the levels of blood sugar in insulin-administered patients, patients with high blood glucose levels and patients with a change of therapy.

World Hemoglobin (Hb) A1c monitoring market is projected to expand to US$272 million by 2012, as stated by Global Industry Analysts, I
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Global Hemoglobin A1c Monitoring Market to Touch $272 Million by 2012, According to New Report by Global Industry Analysts, Inc.
Global Hemoglobin A1c Monitoring Market to Touch $272 Million by 2012, According to New Report by Global Industry Analysts, Inc.
Other Medicine News:Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 2Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 3Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 3Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 4Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 5Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 6Health News:American Psychiatric Foundation Hosts a Benefit for New Orleans Mental Health Organizations as a Part of the Institute for Psychiatric Services Conference 2Health News:New research may show why some prostate cancer recurs after treatment 2Health News:New research may show why some prostate cancer recurs after treatment 3Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 2Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 3
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Study Reveals Evidence of Heart Disease in Ancient Egyptian Mummies 61577 1Study Reveals Evidence of Heart Disease in Ancient Egyptian Mummies 61577 2Doctors Research Group Receives FDA Clearance for U S Distribution of KRYPTONITE 28TM 29 Bone Cement 14882 1Doctors Research Group Receives FDA Clearance for U S Distribution of KRYPTONITE 28TM 29 Bone Cement 14882 2Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 1Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 2Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 3Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 4